Letrozole Hilma Biocare

Specifications:

Company: Hilma Biocare
Active Half-life (Days):  2-3 days
Group: Aromatase inhibitor
Subgroup: Oral/tablets
Dosage: 2.5 mg/tab
Application (Men): 0.5 to 1 mg throughout 1 to 3 days
Product pack: 30 tab.
Content (active): Letrozole
Retains water: No
Aromatization: No

Product Description

Letrozole is an antitumor agent, a non-steroidal selective inhibitor of the aromatase enzyme. Widely used in medicine as a part of post-menopausal therapy in women and breast cancer treatment. Among athletes gained recognition for strong anti-estrogenic properties and raised muscle definition. Like Anastroloze(Arimidex), its effect is up to 5 times stronger, eliminating adverse reactions from anabolic steroid use. Letrozole can suppress estrogen levels in the body, almost wholly shielding from raised estradiol levels.

Effects:

By using Letrozole athletes can almost wholly suppress estrogen level in the body and protects themselves against aromatization.

Side-Effects:

The most common side effects attributed to Letrozole are skin rash, nausea, abdominal pain, fatigue, dizziness, headache, raised Low-density cholesterol levels and liver enzymes.

Protection:

Preliminary blood test should be conducted before using Letrozole. Results in colossal estradiol reduction and increasing the effectiveness of your cycle. Letrozole served as an anti-estrogenic drug and was used as a part of PCT.

Stacking:

Letrozole is most effective during PCT but can be stacked with clomiphene or other steroids as a part of the cycle.